JNBA Financial Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$80.3K Hold
1,676
0.01% 269
2026
Q1
$61.6K Hold
1,676
0.01% 280
2025
Q4
$85.3K Hold
1,676
0.01% 255
2025
Q3
$93K Hold
1,676
0.01% 237
2025
Q2
$116K Sell
1,676
-310
-16% -$21.1K 0.01% 207
2025
Q1
$138K Hold
1,986
0.01% 196
2024
Q4
$171K Sell
1,986
-201
-9% -$21.7K 0.02% 182
2024
Q3
$260K Sell
2,187
-2,000
-48% -$267K 0.03% 167
2024
Q2
$598K Sell
4,187
-1,387
-25% -$184K 0.06% 120
2024
Q1
$716K Buy
5,574
+164
+3% +$19.5K 0.08% 116
2023
Q4
$560K Sell
5,410
-158
-3% -$15.6K 0.06% 125
2023
Q3
$506K Hold
5,568
0.06% 125
2023
Q2
$451K Hold
5,568
0.05% 135
2023
Q1
$443K Sell
5,568
-50
-0.9% -$3.55K 0.06% 134
2022
Q4
$380K Sell
5,618
-5,080
-47% -$298K 0.05% 145
2022
Q3
$533K Sell
10,698
-2,426
-18% -$130K 0.08% 120
2022
Q2
$731K Sell
13,124
-220
-2% -$12.2K 0.11% 106
2022
Q1
$741K Hold
13,344
0.1% 110
2021
Q4
$747K Hold
13,344
0.09% 106
2021
Q3
$641K Hold
13,344
0.09% 110
2021
Q2
$559K Hold
13,344
0.08% 115
2021
Q1
$450K Hold
13,344
0.07% 125
2020
Q4
$466K Buy
13,344
+600
+5% +$20.7K 0.08% 114
2020
Q3
$442K Hold
12,744
0.09% 100
2020
Q2
$417K Hold
12,744
0.09% 104
2020
Q1
$384K Hold
12,744
0.09% 101
2019
Q4
$369K Hold
12,744
0.07% 110
2019
Q3
$329K Hold
12,744
0.07% 113
2019
Q2
$325K Buy
12,744
+1,290
+11% +$31.9K 0.07% 117
2019
Q1
$300K Buy
11,454
+10,454
+1,045% +$257K 0.06% 118
2018
Q4
$23K Buy
+1,000
New +$22.2K 0.01% 286
2018
Q3
Sell
-1,000
Closed -$23K 632
2018
Q2
$23K Hold
1,000
﹤0.01% 298
2018
Q1
$25K Sell
1,000
-1,240
-55% -$32.6K 0.01% 289
2017
Q4
$60K Hold
2,240
0.01% 207
2017
Q3
$54K Sell
2,240
-3,958
-64% -$89.4K 0.01% 205
2017
Q2
$133K Hold
6,198
0.03% 145
2017
Q1
$106K Sell
6,198
-676
-10% -$11.8K 0.03% 159
2016
Q4
$123K Buy
6,874
+2,590
+60% +$47K 0.03% 150
2016
Q3
$89K Sell
4,284
-2,514
-37% -$62.3K 0.01% 391
2016
Q2
$183K Sell
6,798
-292
-4% -$8.01K 0.05% 123
2016
Q1
$192K Sell
7,090
-4,800
-40% -$129K 0.07% 104
2015
Q4
$345K Sell
11,890
-350
-3% -$9.69K 0.13% 73
2015
Q3
$332K Sell
12,240
-1,400
-10% -$39.6K 0.14% 67
2015
Q2
$373K Sell
13,640
-2,450
-15% -$68.9K 0.14% 66
2015
Q1
$430K Hold
16,090
0.17% 61
2014
Q4
$340K Buy
16,090
+2,800
+21% +$62.5K 0.14% 70
2014
Q3
$316K Buy
13,290
+190
+1% +$4.37K 0.14% 68
2014
Q2
$303K Buy
13,100
+200
+2% +$4.42K 0.15% 71
2014
Q1
$294K Hold
12,900
0.15% 67
2013
Q4
$238K Hold
12,900
0.13% 78
2013
Q3
$218K Buy
12,900
+2,400
+23% +$40.4K 0.14% 81
2013
Q2
$163K Buy
+10,500
New +$175K 0.11% 89

Other funds holding NVO

JNBA Financial Advisors's NVO Position: Q2 2026 in Review

JNBA Financial Advisors held its Novo Nordisk (NVO) position steady in Q2 2026 at 1,676 shares worth $80.3K. The position accounts for 0.01% of the portfolio, ranked #269.

JNBA Financial Advisors first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $747K in Q4 2021. 436 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • JNBA Financial Advisors held 1,676 shares of Novo Nordisk worth $80.3K as of Q2 2026.
  • JNBA Financial Advisors left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.01% of JNBA Financial Advisors's portfolio in Q2 2026, its #269 holding.
  • JNBA Financial Advisors first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
  • JNBA Financial Advisors's Novo Nordisk position peaked at $747K in Q4 2021.
  • 436 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.